T. Rowe Price Investment Management, Inc. Third Harmonic Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,830,248 shares of THRD stock, worth $34.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,830,248
Previous 1,349,234
109.77%
Holding current value
$34.4 Million
Previous $17.5 Million
118.63%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$133 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$70.2 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$53 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$38.7 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$35.9 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $490M